IFGL Refractories Limited

₹26.7 crore

ds will no longer be impacted by the annual non-cash goodwill amortization charge of approximately ₹26.7 crores. Reflecting our confidence in the Company's long-term prospects and commitment to shareholder val

₹2.15

rm prospects and commitment to shareholder value creation, the Board has recommended a dividend of ₹2.15 per equity share for FY26. Backed by a strengthened leadership team, improving industry fundamentals

10%

mance Highlights Total Revenue (Rs. Crs) EBITDA (Rs. Crs) Adj. PAT (Rs. Crs)* Key Highlights +10% 1,117 1,014 -10% 140 126 -23% 58 44 +2% 273 278 -19% 40 33 -22% 17 13 Q4FY25 Q4F

23%

Crs) EBITDA (Rs. Crs) Adj. PAT (Rs. Crs)* Key Highlights +10% 1,117 1,014 -10% 140 126 -23% 58 44 +2% 273 278 -19% 40 33 -22% 17 13 Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY2

2%

(Rs. Crs) Adj. PAT (Rs. Crs)* Key Highlights +10% 1,117 1,014 -10% 140 126 -23% 58 44 +2% 273 278 -19% 40 33 -22% 17 13 Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Q4FY

19%

PAT (Rs. Crs)* Key Highlights +10% 1,117 1,014 -10% 140 126 -23% 58 44 +2% 273 278 -19% 40 33 -22% 17 13 Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25

22%

* Key Highlights +10% 1,117 1,014 -10% 140 126 -23% 58 44 +2% 273 278 -19% 40 33 -22% 17 13 Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Gross

47%

FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Gross Margin (%) EBITDA Margins (%) Adj. PAT Margin (%)* 47% 43% 48% 45% 15% 14% 12% 6% 6% 11% 5% 4% Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY2

43%

FY26 Q4FY25 Q4FY26 FY25 FY26 Gross Margin (%) EBITDA Margins (%) Adj. PAT Margin (%)* 47% 43% 48% 45% 15% 14% 12% 6% 6% 11% 5% 4% Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY

48%

Q4FY25 Q4FY26 FY25 FY26 Gross Margin (%) EBITDA Margins (%) Adj. PAT Margin (%)* 47% 43% 48% 45% 15% 14% 12% 6% 6% 11% 5% 4% Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Q

45%

Y25 Q4FY26 FY25 FY26 Gross Margin (%) EBITDA Margins (%) Adj. PAT Margin (%)* 47% 43% 48% 45% 15% 14% 12% 6% 6% 11% 5% 4% Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Q4FY25

15%

Q4FY26 FY25 FY26 Gross Margin (%) EBITDA Margins (%) Adj. PAT Margin (%)* 47% 43% 48% 45% 15% 14% 12% 6% 6% 11% 5% 4% Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4FY26 FY25 FY26 Q4FY25 Q4F

“Infrastructure Overview Free Homeopathy Health Check -up Camp Food – kit distribution to TB Patients Science Exhibition Block / District & State level Participation Eye Check-up Camp 29 Table of Content 01 Q4 & FY26 Performance Highlights 02 IFGL Refractories at a Glance Agenda 03 Historical Performance Highlights 04 Annexure Consolidated Historical Financial Highlights Total Income (Rs.”

“Crs) 1,904.0 212.8 77.5 79.2 81.7 1,658.3 1,670.4 1,399.7 1,275.4 158.5 166.1 146.0 145.8 43.0 39.9 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24# FY25 FY25 FY22 FY23 FY24 FY25 FY26* #Before One-off provision *Adjusted for Labour Code Impact 31 Consolidated Historical Profit & Loss Statement Particulars [Rs.”

“Crs) 202.4 195.6 262.7 148.5 163.0 87.1 194.3 202.1 169.4 121.9 FY22 FY23 FY24 FY25 FY26 73.7 33.0 -45.9 -39.1 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 -175.6 Net Debt : Equity (x) Net Debt : Ebitda (x) FY22 FY23 FY24 FY25 0.03 FY26 0.06 FY22 FY23 FY24 FY25 FY26 0.51 0.23 -0.05 -0.04 -0.28 -0.23 -0.19 -1.11 Our cash & equivalents stood at 122 Crs in FY26 while our net debt position as on 31st Mar-26 stood at 74 Crs 34 Key Consolidated Historical Ratios Working Capital (Rs.”

“Crs) 604.4 528.3 465.7 446.5 344.2 302.0 300.7 259.4 404.7 411.4 425.1 349.8 325.0 359.4 272.0 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 Payables (Rs.”

“Crs) Return on Equity (%) = Net Profit / Networth Return on Capital Employed (%) = EBIT / Total Capital Employed 187.2 186.2 179.3 235.8 232.0 8.3% 7.9% 7.6% 11.3% 10.4% 9.4% 3.9% 3.0% 6.3% 5.4% FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24 FY25 FY26 Total Capital employed includes total equity & total long-term debt.”

“FY22 FY23 FY24 Particulars (Rs.) Consolidated Book Value Per Share Consolidated Earning Per Share Dividend Per Share FY22 259.2 21.5 7.0 FY23 278.9 21.9 7.0 FY25 FY24 297.5 22.66 7.0 FY25 307.2 11.93 7.0 On 21st July 2025, Company have issued and allotted 3,60,39,312 Equity Shares of Rs 10/- each as Bonus shares in the ratio 1:1.”

“21.5% FY26 FY26 163.0 4.81 2.15 36 Table of Content 01 Q4 & FY26 Performance Highlights 02 IFGL Refractories at a Glance Agenda 03 Historical Performance Highlights 04 Annexure Growth drivers of Indian Steel industry Infrastructure development and demand from the various sectors Huge export opportunity for India due to its low cost advantage & Centre aims at covering refractories in PLI 2.0 to support steel industry Growth Drivers will boost usage of refractory products significantly.”

“Iron and steel industry accounts for around 70% of the refractories market share Steel Demand In Union Budget it is proposed to raise the capital expenditure target by 33% to Rs.”

“10 lakh crore for the next fiscal year, which is 3.3% of the country's economic output, as the government hopes to shore up demand and consumption in the economy.”

Kalunga Shilpanchal Bidyalaya

1

Investor Relations Advisor

1

Kalunga Shilpanchal Bidyalaya

Infrastructure Overview Free Homeopathy Health Check -up Camp Food – kit distribution to TB Patients Science Exhibition Block / District & State level Participation Eye Check-up Camp 29 Table of Content 01 Q4 & FY26 Performance Highlights 02 IFGL Refractories at a Glance Agenda 03 Historical Performance Highlights 04 Annexure Consolidated Historical Financial Highlights Total Income (Rs. Crs) EBITDA (Rs. Crs) Profit After Tax (Rs. Crs) 1,904.0 212.8 77.5 79.2 81.7 1,658.3 1,670.4 1,399.7 1,275.4 158.5 166.1 146.0 145.8 43.0 39.9 FY22 FY23 FY24 FY25 FY26 FY22 FY23 FY24# FY25 FY25 FY22 FY23 FY24 FY25 FY26* #Before One-off provision *Adjusted for Labour Code Impact 31 Consolidated Historical Profit & Loss Statement Particulars [Rs. Crs.] Total Income Materials consumed Employee Expenses Other Expenses EBITDA before Exceptional Item EBITDA Margins (%) before Exceptional Item Exceptional Item (Provision for Doubtful Debt) Reported EBITDA Depreciation & Amortization Goodwill amortized* Finan

Investor Relations Advisor

IFGL Refractories Ltd. CIN - L51909OR2007PLC027954 Mrs. Mansi Damani mansi.damani@ifgl.in www.ifglgroup.com Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285 Mr. Sagar Shroff / Mr. Vatsal Shah sagar.shroff@sgapl.net / vatsal.shah@sgapl.net +91 98205 19303 / +91 88796 59884 www.sgapl.net